InvestorX
SEDAR® Issuer number:
00008864
Company name:
HILLESTAD PHARMACEUTICALS INC.
Document type:
AB Form 13-501F2 and/or ON Form 13-502F2 (Class 2 Reporting Issuers - Participation Fee)
Project number:
06078530
Filing date:
01-29-2024